Lilly criticized for new Evista ads. - Financial Advertising
"This is about educating those women about the additional benefit this drug has to offer," said Deirdre Ibsen, Lilly's director of osteoporosis marketing. "That will obviously translate into something more (in sales) for Evista. What it is at this point, we don't know Don't know (DK, DKed)"Don't know the trade." A Street expression used whenever one party lacks knowledge of a trade or receives conflicting instructions from the other party. ." But some breast-cancer advocacy groups take issue with the ads. They say Evista's risks are too great for healthy women to consider using.
such as "Good Housekeeping Good Housekeeping is a women's magazine owned by the Hearst Corporation, featuring articles about women's interests, product testing by The Good Housekeeping Institute, recipes, diet, health as well as literary articles. ." The company said the new ads are not a broad-market push, but are targeted at a fairly narrow market of postmenopausal women who have osteoporosis.
"This is about educating those women about the additional benefit this drug has to offer," said Deirdre Ibsen, Lilly's director of osteoporosis marketing. "That will obviously translate into something more (in sales) for Evista. What it is at this point, we don't know Don't know (DK, DKed)"Don't know the trade." A Street expression used whenever one party lacks knowledge of a trade or receives conflicting instructions from the other party. ." But some breast-cancer advocacy groups take issue with the ads. They say Evista's risks are too great for healthy women to consider using.
They say only a small percentage of women might avoid breast cancer by taking a drug like Evista. "This is not the approach we should be taking," said Brenda Salgado, program manager of Breast Cancer Awareness in San Francisco. "We believe that any pill powerful enough to lower the incidence of breast cancer will most certainly cause other health problems and diseases. Why should we substitute one problem for another?" Carolina Hinestrosa, executive vice president of the National Breast Cancer Coalition The National Breast Cancer Coalition (NBCC) is a grassroots membership organization, comprised of hundreds of member organizations and tens of thousands of individuals dedicated to ending breast cancer through action and advocacy. in Washington, said many women who take Evista will not need it and won't benefit from it. "Yet there are many vulnerable women who are afraid of breast cancer," she said.
...
Last we heard of Fablyn, an experimental bone drug for the treatment of postmenopausal women, U.S. regulators were holding off on approval after FDA staff and outside reviewers raised concerns and Pfizer, the pill’s maker, was shopping it around to other companies.